About 200 reports

Aesthetic Devices - Medical Devices Pipeline Assessment, 2015

313 pages • By Global Data

Aesthetic Devices - Medical Devices Pipeline Assessment, 2015SummaryGlobalData's Medical Devices sector report, “Aesthetic Devices - Medical Devices Pipeline Assessment, 2015" provides an overview of Aesthetic Devices currently in pipeline stage.The report provides comprehensive information on the pipeline products...

3 200 4 000 2 304
Jan 2016

Skin Disease Treatment Technologies and Global Markets

128 pages • By BCC Research

This BCC Research report provides detailed market, technology and industry analyses to help readers quantify and qualify the market for drugs used in the treatment of the major skin diseases. Important trends are identified and sales forecasts by product categories and major country markets are provided through 2020. Use this...

5 320 6 650 4 256
Jan 2016

Angioedema-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight

SUMMARYDelveInsight’s Report, “Angioedema-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Angioedema Report is to understand the market and pipeline...

1 600 2 000 1 280
Jan 2016

Cellulitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight

SUMMARYDelveInsight’s Report, “Cellulitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Cellulitis Report is to understand the market and pipeline...

1 600 2 000 1 280
Jan 2016

Acne Vulgaris-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight

SUMMARYDelveInsight’s Report, “Acne Vulgaris-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Acne Vulgaris Report is to understand the market...

1 600 2 000 1 280
Jan 2016

Genital Warts (Condylomata Acuminata)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight

SUMMARYDelveInsight’s Report, “Genital Warts (Condylomata Acuminata)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Genital Warts (Condylomata...

1 600 2 000 1 280
Jan 2016

Dermatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight

SUMMARYDelveInsight’s Report, “Dermatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Dermatitis Report is to understand the market and pipeline...

1 600 2 000 1 280
Jan 2016

Lichen Simplex Chronicus (Neurodermatitis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight

SUMMARYDelveInsight’s Report, “Lichen Simplex Chronicus (Neurodermatitis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Lichen Simplex Chronicus...

1 600 2 000 1 280
Jan 2016

Actinic Keratosis-Pipeline Insights, 2016

By Delve Insight

SUMMARYDelveInsight’s, “ Actinic Keratosis-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Actinic Keratosis. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase...

1 000 1 250 800
Jan 2016

Systemic Sclerosis (Scleroderma)-Pipeline Insights, 2016

By Delve Insight

SUMMARYDelveInsight’s, “ Systemic Sclerosis (Scleroderma)-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Systemic Sclerosis (Scleroderma). The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical,...

1 000 1 250 800
Jan 2016

Xerosis (Dry Skin)-Pipeline Insights, 2016

By Delve Insight

SUMMARYDelveInsight’s, “ Xerosis (Dry Skin)-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Xerosis (Dry Skin). The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase...

1 000 1 250 800
Jan 2016

Hirsutism-Pipeline Insights, 2016

By Delve Insight

SUMMARYDelveInsight’s, “ Hirsutism-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Hirsutism. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration....

1 000 1 250 800
Jan 2016

Cutaneous Lupus Erythematosus-Pipeline Insights, 2016

By Delve Insight

SUMMARYDelveInsight’s, “ Cutaneous Lupus Erythematosus-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Cutaneous Lupus Erythematosus. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND,...

1 000 1 250 800
Jan 2016

Pruritus-Pipeline Insights, 2016

By Delve Insight

SUMMARYDelveInsight’s, “ Pruritus-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Pruritus. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration....

1 000 1 250 800
Jan 2016

Chronic Urticaria Or Hives-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight

SUMMARYDelveInsight’s Report, “Chronic Urticaria Or Hives-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Chronic Urticaria Or Hives Report is...

1 600 2 000 1 280
Jan 2016

Hereditary Angioedema (HAE)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight

SUMMARYDelveInsight’s Report, “Hereditary Angioedema (HAE)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Hereditary Angioedema (HAE) Report...

1 600 2 000 1 280
Jan 2016

Onychomycosis (Tinea Unguium)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight

SUMMARYDelveInsight’s Report, “Onychomycosis (Tinea Unguium)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Onychomycosis (Tinea Unguium) Report...

1 600 2 000 1 280
Jan 2016

Epidermolysis Bullosa-Pipeline Insights, 2016

By Delve Insight

SUMMARYDelveInsight’s, “ Epidermolysis Bullosa-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Epidermolysis Bullosa. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase...

1 000 1 250 800
Jan 2016

Genital Warts (Condylomata Acuminata)-Pipeline Insights, 2016

By Delve Insight

SUMMARYDelveInsight’s, “ Genital Warts (Condylomata Acuminata)-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Genital Warts (Condylomata Acuminata). The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical,...

1 000 1 250 800
Jan 2016

Subacute Cutaneous Lupus Erythematosus (SCLE)-Pipeline Insights, 2016

By Delve Insight

SUMMARYDelveInsight’s, “ Subacute Cutaneous Lupus Erythematosus (SCLE)-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Subacute Cutaneous Lupus Erythematosus (SCLE). The DelveInsight’sReport covers the product profiles in various stages of development including...

1 000 1 250 800
Jan 2016

Systemic Mastocytosis-Pipeline Insights, 2016

By Delve Insight

SUMMARYDelveInsight’s, “ Systemic Mastocytosis-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Systemic Mastocytosis. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase...

1 000 1 250 800
Jan 2016

Actinic (Solar) Keratosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight

SUMMARYDelveInsight’s Report, “Actinic (Solar) Keratosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Actinic (Solar) Keratosis Report is...

1 600 2 000 1 280
Jan 2016

Chronic Plaque Psoriasis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight

SUMMARYDelveInsight’s Report, “Chronic Plaque Psoriasis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Chronic Plaque Psoriasis Report is to...

1 600 2 000 1 280
Jan 2016

Contact Dermatitis-Pipeline Insights, 2016

By Delve Insight

SUMMARYDelveInsight’s, “ Contact Dermatitis-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Contact Dermatitis. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase...

1 000 1 250 800
Jan 2016

HIV-Associated Lipodystrophy Syndrome-Pipeline Insights, 2016

By Delve Insight

SUMMARYDelveInsight’s, “ HIV-Associated Lipodystrophy Syndrome-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the HIV-Associated Lipodystrophy Syndrome. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical,...

1 000 1 250 800
Jan 2016

Lipodystrophy-Pipeline Insights, 2016

By Delve Insight

SUMMARYDelveInsight’s, “ Lipodystrophy-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Lipodystrophy. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and...

1 000 1 250 800
Jan 2016

Atopic Dermatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight

SUMMARYDelveInsight’s Report, “Atopic Dermatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Atopic Dermatitis Report is to understand the...

1 600 2 000 1 280
Jan 2016

Axillary Hyperhidrosis-Pipeline Insights, 2016

By Delve Insight

SUMMARYDelveInsight’s, “ Axillary Hyperhidrosis-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Axillary Hyperhidrosis. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase...

1 000 1 250 800
Jan 2016

Plaque Psoriasis (Psoriasis Vulgaris)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight

SUMMARYDelveInsight’s Report, “Plaque Psoriasis (Psoriasis Vulgaris)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Plaque Psoriasis (Psoriasis...

1 600 2 000 1 280
Jan 2016

Acute Cutaneous Lupus Erythematosus (ACLE)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight

SUMMARYDelveInsight’s Report, “Acute Cutaneous Lupus Erythematosus (ACLE)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Acute Cutaneous Lupus...

1 600 2 000 1 280
Jan 2016